Biocidal Products Regulation — BPR
The Biocidal Products Regulation — BPR, also known as Regulation — EU — No 528/2012, is the main European legislation governing the placing on the market and use of biocidal products in the European Union.
The regulation entered into force on 1 September 2013 and replaced Directive 98/8/EC.
Its purpose is to ensure a high level of protection for human health, animal health and the environment, while also supporting competitiveness and innovation in the biocidal products sector.
What Are Biocidal Products?
Biocidal products are substances or mixtures used to control organisms considered harmful, such as microorganisms, insects and rodents.
They include products such as:
- Disinfectants.
- Insecticides.
- Fungicides.
- Wood preservatives.
Biocides play a critical role in various sectors, from public health and industrial production to the preservation of materials and products.
Key Elements of the BPR
The BPR sets out the procedures for the approval of active substances and the authorisation of biocidal products in the EU.
The main procedures include:
- Evaluation and approval of active substances.
- Authorisation of biocidal products.
- Mutual recognition of authorisations between Member States.
Approval of Active Substances
Before an active substance can be used in biocidal products, it must first be approved at European level.
This process includes the assessment of data relating to the substance’s:
- Effectiveness.
- Safety for human health.
- Safety for animal health.
- Environmental impact.
The evaluation is carried out by the competent authorities of Member States, while the European Chemicals Agency — ECHA provides scientific support and coordination.
Authorisation of Biocidal Products
After the active substance has been approved, biocidal products containing it must be authorised before they can be placed on the EU market.
Authorisation may take place:
- At national level, through the competent authorities of Member States.
- Through the Union authorisation procedure, coordinated via ECHA and assessed at EU level.
The evaluation of biocidal products includes an assessment of their effectiveness and of the risks that may arise from their use.
Mutual Recognition of Authorisations
The BPR also provides for the mutual recognition of authorisations between Member States, facilitating the movement of biocidal products within the EU.
This means that an authorisation granted in one Member State may be recognised in other Member States, provided that the relevant national requirements are met.
Benefits of the BPR
The Biocidal Products Regulation offers several important benefits.
First, it improves the protection of human health and the environment through strict evaluation and authorisation procedures.
This ensures that biocidal products placed on the EU market are safe and effective.
Second, the regulation strengthens the harmonisation of rules within the EU internal market, making trade in biocidal products between Member States easier.
The mutual recognition procedure reduces barriers for businesses and contributes to the creation of a level playing field.
Third, the regulation promotes innovation by encouraging companies to develop new and improved biocidal products.
Strict safety requirements and the need for continuous research and development create incentives for the production of safer and more effective products.
Challenges and Criticism
Despite its benefits, the BPR also presents several challenges.
The authorisation process can be costly and time-consuming for companies, especially for small and medium-sized enterprises — SMEs — which may not have the same resources as large multinational companies.
The requirements for collecting and submitting extensive data can represent a significant financial and administrative burden.
In addition, continuous changes and updates to the regulatory framework may create uncertainty and additional obligations for companies, which must constantly monitor developments and adapt to new requirements.
Conclusion
The Biocidal Products Regulation — BPR is an important tool for the management of biocidal products in the European Union.
It provides a clear and harmonised framework for the approval and authorisation of biocides, promoting the protection of human health, animal health and the environment.
Despite the challenges it creates, the BPR strengthens safety and trust in the biocidal products market, while also supporting innovation and the competitiveness of European companies.
Through its strict approach and demanding evaluation procedures, the regulation contributes to the creation of a safer and more responsible environment for the use of biocidal products in the EU.